🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III randomised, double-blind, multi-centre study to evaluat...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-01-04
Trial ID
NCT03737643
Treatments Being Tested
This is a Phase III, randomised, double-blind, multicentre, international s...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-02-07
Trial ID
NCT05221840
Treatments Being Tested
A study to assess the efficacy and safety of durvalumab in combination with...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-05-05
Trial ID
NCT04269200
Treatments Being Tested
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-ce...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-09-27
Trial ID
NCT03703297
Treatments Being Tested
A global study to evaluate transarterial chemoembolization (TACE) in combin...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-11-30
Trial ID
NCT03778957
Treatments Being Tested
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-04-16
Trial ID
NCT03875235
Treatments Being Tested
This is a Phase III, randomised, double-blind, placebo-controlled, multicen...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-11-27
Trial ID
NCT03706690
Treatments Being Tested
Adjuvant Durvalumab vs Placebo for 1 year after complete resection of esoph...
Status
Unknown
Location
Samsung Medical Center
Start Date
2016-02
Trial ID
NCT02520453
Treatments Being Tested
This is a Phase III, randomized, placebo-controlled, double-blind, multi-ce...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-03-06
Trial ID
NCT03833154
Treatments Being Tested
This is a randomized, multi-center, double-blind, placebo-controlled, globa...
Status
Completed
Location
Research Site
Start Date
2019-02-15
Trial ID
NCT03830866
Treatments Being Tested